Tuesday, March 17, 2026

HD Hyundai Partnership Bolsters European Fuel Cell Maker, Reinforcing US Ally’s Climate Goals

Elcogen opens a new factory in Estonia, significantly boosting fuel cell production capacity, backed by HD Hyundai's investment.

Bank of Korea Flags U.S. Tariff and Policy Uncertainty: Can South Korea’s KOSPI Stay Firm After Crossing 5,900?

The Bank of Korea warns of volatility in stock markets due to U.S. tariffs but remains optimistic about economic recovery driven by semiconductors.

Seoul Brings London and New York Ferry Experts to the Table: What the Han River Bus Needs to Avoid a Subsidy Trap

Seoul Mayor Oh Se Hoon addresses challenges in Han River Bus operations, emphasizing improvement and learning from global experts.

Tag: Cartistem

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us